Abstract
Patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis may have concomitant mitral stenosis (MS). Hemodynamic impact of TAVR on mitral gradient is unclear, and there is no consensus strategy for treatment of MS in this patient population. The aim of this study
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
